Thermo Fisher Scientific IncChange company Symbol lookupSelect an option...TMO Thermo Fisher Scientific IncVICR Vicor CorpGTEC Greenland Technologies Holding CorpSTR Sitio Royalties CorpCWD CaliberCos IncLNTH Lantheus Holdings IncDFIN Donnelley Financial Solutions IncSY So-Young International IncGOTU Gaotu Techedu IncSGDVV Safe & Green Development CorpGo
Change company Symbol lookup
Select an option...
TMO Thermo Fisher Scientific Inc
VICR Vicor Corp
GTEC Greenland Technologies Holding Corp
STR Sitio Royalties Corp
CWD CaliberCos Inc
LNTH Lantheus Holdings Inc
DFIN Donnelley Financial Solutions Inc
SY So-Young International Inc
GOTU Gaotu Techedu Inc
SGDVV Safe & Green Development Corp
Health Care : Life Sciences Tools & Services | Large Cap Blend
Company profileThermo Fisher Scientific Inc. is engaged in serving science. The Company’s Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment provides an offering of instruments and the supporting consumables, software and services that are used for a range of applications. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments, and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and food safety laboratories. The Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. Its brands include Thermo Scientific, Applied Biosystems, and others. It also provides regulatory-grade, real-world evidence for approved medical treatments and therapies.
|
|
|
|
| |
| Latest Earnings Missed Consensus (Q2 ending 06/2023) | Next Earnings Announcement | ||||||
|---|---|---|---|---|---|---|---|
| Q2 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced July 26, 2023 | $5.15 | Q2 Consensus of 22 analysts | $5.43 | Difference from consensus | -5.07% | Q3 Earnings will announce | (Unconfirmed) October 24, 2023 |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
TMO's fiscal year ends in December
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.